In a world where health concerns are increasingly prevalent, the role of the FDA in approving medications like semaglutide remains vital in promoting public health and improving patient outcomes.
Adults with type 2 diabetes prescribed semaglutide were matched, 1:2, with adults prescribed a non-GLP-1 diabetes drug, and adults with overweight or obesity prescribed semaglutide were matched, 1:2, with adults prescribed a non-GLP-1 obesity medication
Theoharides et al., 2008, 2010, 2012a
V., Davis, A
Start at a low semaglutide dose and watch for increased heart rate, blood pressure changes, or unusual nausea over the first 48 weeks
Flexible, Personalized Dosing Allows adjustments based on your response, helping create a more tailored and optimized experience